A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

September 27, 2024

Study Completion Date

September 27, 2024

Conditions

Healthy

Interventions

DRUG

MK-6552

Oral Gelatin Coated Capsule

DRUG

Diltiazem

Oral Extended-Release Capsule

Trial Locations (1)

ICON (Site 0001), Lenexa

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06662396 - A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007) | Biotech Hunter | Biotech Hunter